Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1981 2
1982 1
1983 4
1984 8
1985 16
1986 15
1987 55
1988 32
1989 25
1990 17
1991 11
1992 9
1993 13
1994 9
1995 9
1996 5
1997 8
1998 12
1999 21
2000 20
2001 11
2002 18
2003 20
2004 12
2005 19
2006 10
2007 20
2008 16
2009 15
2010 25
2011 26
2012 27
2013 37
2014 36
2015 43
2016 39
2017 52
2018 71
2019 75
2020 123
2021 107
2022 142
2023 149
2024 54

Text availability

Article attribute

Article type

Publication date

Search Results

1,285 results

Results by year

Filters applied: . Clear all
Page 1
Minoxidil in the treatment of androgenetic alopecia.
Goren A, Naccarato T. Goren A, et al. Dermatol Ther. 2018 Sep;31(5):e12686. doi: 10.1111/dth.12686. Epub 2018 Aug 28. Dermatol Ther. 2018. PMID: 30155952 Review.
In the US, minoxidil is approved over-the-counter (OTC) at a maximum concentration of 5%. In this review, we summarize the findings of the pivotal studies used in support of the drug's approval as well as recent discoveries and novel developments in the use of minoxidil
In the US, minoxidil is approved over-the-counter (OTC) at a maximum concentration of 5%. In this review, we summarize the findings o …
Off-Label Use of Topical Minoxidil in Alopecia: A Review.
Stoehr JR, Choi JN, Colavincenzo M, Vanderweil S. Stoehr JR, et al. Am J Clin Dermatol. 2019 Apr;20(2):237-250. doi: 10.1007/s40257-018-0409-y. Am J Clin Dermatol. 2019. PMID: 30604379 Review.
Topical minoxidil is a well-known and often-utilized drug in dermatological practice for the treatment of alopecia. ...Conditions for which the use of topical minoxidil has been reported include telogen effluvium, alopecia areata (AA), scarring alop
Topical minoxidil is a well-known and often-utilized drug in dermatological practice for the treatment of alopecia. ...Conditi …
Comprehensive review of oral minoxidil in alopecia.
Modha JD, Pathania YS. Modha JD, et al. J Cosmet Dermatol. 2022 Nov;21(11):5527-5531. doi: 10.1111/jocd.15324. Epub 2022 Sep 20. J Cosmet Dermatol. 2022. PMID: 36065675 Review.
The compliance of the patients is important in reaping results in alopecia. Minoxidil has come a long-way finding its use from topical formulations to systemic at lower dose in different alopecia. OBJECTIVE: The objective of this article is to discuss various …
The compliance of the patients is important in reaping results in alopecia. Minoxidil has come a long-way finding its use from …
Oral minoxidil treatment for hair loss: A review of efficacy and safety.
Randolph M, Tosti A. Randolph M, et al. J Am Acad Dermatol. 2021 Mar;84(3):737-746. doi: 10.1016/j.jaad.2020.06.1009. Epub 2020 Jul 2. J Am Acad Dermatol. 2021. PMID: 32622136 Review.
OBJECTIVE: In recent years, oral minoxidil at low dose has been proposed as a safe alternative. This study reviewed articles in which oral minoxidil was used to treat hair loss to determine its efficacy and safety as an alternative to topical minoxidil. ...RE …
OBJECTIVE: In recent years, oral minoxidil at low dose has been proposed as a safe alternative. This study reviewed articles in which …
Androgenetic Alopecia: Therapy Update.
Devjani S, Ezemma O, Kelley KJ, Stratton E, Senna M. Devjani S, et al. Drugs. 2023 Jun;83(8):701-715. doi: 10.1007/s40265-023-01880-x. Epub 2023 May 11. Drugs. 2023. PMID: 37166619 Free PMC article. Review.
Androgenetic alopecia (AGA), also known as male pattern hair loss (MPHL) or female pattern hair loss (FPHL), is the most common form of alopecia worldwide, and arises from an excessive response to androgens. ...There are only two US Food and Drug Administration (FDA …
Androgenetic alopecia (AGA), also known as male pattern hair loss (MPHL) or female pattern hair loss (FPHL), is the most common form …
Low-dose oral minoxidil as treatment for non-scarring alopecia: a systematic review.
Sharma AN, Michelle L, Juhasz M, Muller Ramos P, Atanaskova Mesinkovska N. Sharma AN, et al. Int J Dermatol. 2020 Aug;59(8):1013-1019. doi: 10.1111/ijd.14933. Epub 2020 Jun 9. Int J Dermatol. 2020. PMID: 32516434
BACKGROUND: Topical minoxidil has been used for almost 40 years to treat alopecia. There is growing evidence supporting off-label use of low-dose oral minoxidil. ...CONCLUSION: Oral minoxidil is a safe and successful treatment of androgenic alopecia
BACKGROUND: Topical minoxidil has been used for almost 40 years to treat alopecia. There is growing evidence supporting off-la …
Minoxidil: a comprehensive review.
Gupta AK, Talukder M, Venkataraman M, Bamimore MA. Gupta AK, et al. J Dermatolog Treat. 2022 Jun;33(4):1896-1906. doi: 10.1080/09546634.2021.1945527. Epub 2021 Jul 20. J Dermatolog Treat. 2022. PMID: 34159872 Review.
Topical minoxidil (5% foam, 5% solution, and 2% solution) is FDA-approved for androgenetic alopecia (AGA) in men and women.Mechanism of action: Minoxidil acts through multiple pathways (vasodilator, anti-inflammatory agent, inducer of the Wnt/beta-catenin sig …
Topical minoxidil (5% foam, 5% solution, and 2% solution) is FDA-approved for androgenetic alopecia (AGA) in men and women.Mec …
Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics.
Nestor MS, Ablon G, Gade A, Han H, Fischer DL. Nestor MS, et al. J Cosmet Dermatol. 2021 Dec;20(12):3759-3781. doi: 10.1111/jocd.14537. Epub 2021 Nov 6. J Cosmet Dermatol. 2021. PMID: 34741573 Free PMC article. Review.
BACKGROUND: Androgenetic alopecia (AGA) is the most common form of hair loss consisting of a characteristic receding frontal hairline in men and diffuse hair thinning in women, with frontal hairline retention, and can impact an individual's quality of life. ...MATERIALS AN …
BACKGROUND: Androgenetic alopecia (AGA) is the most common form of hair loss consisting of a characteristic receding frontal hairline …
Minoxidil-loaded hyaluronic acid dissolving microneedles to alleviate hair loss in an alopecia animal model.
Kim MJ, Seong KY, Kim DS, Jeong JS, Kim SY, Lee S, Yang SY, An BS. Kim MJ, et al. Acta Biomater. 2022 Apr 15;143:189-202. doi: 10.1016/j.actbio.2022.02.011. Epub 2022 Feb 21. Acta Biomater. 2022. PMID: 35202857
Various therapeutic agents have been suggested depending on the cause of the condition and patient sex, and age. Minoxidil (MXD) is commonly used topically to treat alopecia, but its low absorption rate limits widespread use. ...In summary, our results demonstrated …
Various therapeutic agents have been suggested depending on the cause of the condition and patient sex, and age. Minoxidil (MXD) is c …
1,285 results